CORA-BOSAN B43 - TAB DIN 02157713
Health Canada record
| Active ingredient(s) | SODIUM NITROPRUSSIDE 4 D; POTASSIUM CARBONATE 2 D; SQUILL 4 D |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1996 |
| Current status date | 10-Jul-2006 |
| Source | Health Canada DPD |
Establishment licence of the holder
Professional Disposables International Ltd — licence 101748, currently licensed, last inspection rating C (2023-12-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SODIUM NITROPRUSSIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02450089 | SODIUM NITROPRUSSIDE FOR INJECTION | STERIMAX INC | Solution | SODIUM NITROPRUSSIDE 25 MG | Marketed |
| 02479109 | SODIUM NITROPRUSSIDE FOR INJECTION | MARCAN PHARMACEUTICALS INC | Solution | SODIUM NITROPRUSSIDE 25 MG | Marketed |
| 02507404 | SODIUM NITROPRUSSIDE FOR INJECTION | DR REDDY'S LABORATORIES LTD | Solution | SODIUM NITROPRUSSIDE 25 MG | Marketed |
| 00336459 | NIPRIDE | HOSPIRA HEALTHCARE ULC | Powder For Solution | SODIUM NITROPRUSSIDE 50 MG | Cancelled Post Market |
| 02361736 | NIPRIDE | PFIZER CANADA ULC | Solution | SODIUM NITROPRUSSIDE 25 MG | Cancelled Post Market |
International API supply for SODIUM NITROPRUSSIDE
2 valid EDQM Certificates of Suitability from 2 holders. 14 active FDA Drug Master Files.
Request a quote for CORA-BOSAN B43 - TAB